Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Science Translational Medicine|April 8, 2016
Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapseYang Pu, Meng Xu, Yong Liang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2012
Cetuximab-mediated tumor regression depends on innate and adaptive immune responsesXuanming Yang, Xunmin Zhang, Eric D Mortenson, et al.
Nature Medicine|September 25, 2007
Adaptive immune cells temper initial innate responsesKwang Dong Kim, Jie Zhao, Sogyong Auh, et al.
Cell Host & Microbe|July 11, 2014
A BTLA-mediated bait and switch strategy permits Listeria expansion in CD8α(+) DCs to promote long-term T cell responsesXuanming Yang, Xunmin Zhang, Yonglian Sun, et al.
Virologica Sinica|December 31, 2014
Coronavirus MHV-A59 infects the lung and causes severe pneumonia in C57BL/6 miceZhangsheng Yang, Jun Du, Gang Chen, et al.
Cancer Letters|May 7, 2026
IL-12 Augments Adoptive Cell Therapy by Reshaping CD8<sup>+</sup> T Dynamics and Broadening Antitumor ImmunityYue Huang, Xiangming Liu, Yiwei Chen, et al.
Immunity|January 14, 2014
Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infectionXiaohuan Guo, Ju Qiu, Tony Tu, et al.
Cancers|January 12, 2021
Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced ApoptosisHaiyong Wang, Ping Han, Xinyue Qi, et al.
Frontiers in Immunology|December 7, 2020
4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2<sup>nd</sup> Generation Chimeric Antigen Receptor-Modified T CellsQiang Dai, Ping Han, Xinyue Qi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 18, 2021
USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-JAK1-STAT1 signal axisMin Li, Yanqin Xu, Jie Liang, et al.
Pageof 4